Soombit AI raises $9M Series A to move generative imaging beyond X-rays
What's the deal? South Korea's Soombit AIDealroom has a profile for this one. Try Dealroom → has raised US$10.1M in a Series A round led by SV InvestmentDealroom has a profile for this one. Try Dealroom →, with Altos Ventures, Kiwoom InvestmentDealroom has a profile for this one. Try Dealroom →, and iM Investment PartnersDealroom has a profile for this one. Try Dealroom → participating. The company develops generative AI software that drafts preliminary reports from medical images.
Why now? Soombit also secured a place in the Ministry of SMEs and Startups' Scale-up TIPS programme, which provides up to US$2.52M in government-matched R&D funding over three years. The grant is earmarked for multi-sequence CT and MRI solutions and overseas commercialisation.
What's the endgame? The round funds a push beyond chest X-rays into higher-difficulty 3D imaging. Its CT reporting tool, AIRead-CT, is targeted for a 2027 launch and will debut at the RSNA 2026 exhibition in Chicago.
Altos Ventures, which was sole backer of Soombit's US$4.19M seed round in 2024, returned for the Series A. Cumulative investment and funding now totals roughly US$16.8M.
What could go wrong? Moving from 2D X-rays to complex 3D scans is a steep technical jump, and the company's near-term test is clinical validation and regulatory clearance — not funding. Soombit plans to pursue US FDA and European CE certification to support global sales.
The signal: The round lands amid continued investor appetite for radiology AI, including recent rounds for workflow player Rad AI and imaging platform Sirona Medical. Soombit's bet is that generative report-drafting, proven on chest X-rays, can become standard infrastructure for radiologists across more demanding imaging.
Read more: mk.co.kr
Image credit: "Imagen AI for Radiology" by jurvetson, licensed under CC BY 2.0